Acasti Pharma Income Taxes 2014-2024 | GRCE
Acasti Pharma income taxes from 2014 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Acasti Pharma Annual Income Taxes
(Millions of US $) |
| 2024 |
$-2 |
| 2023 |
$-10 |
| 2022 |
$-1 |
| 2021 |
$ |
| 2020 |
$ |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$-0 |
| 2016 |
$ |
| 2015 |
$0 |
| 2015 |
$ |
| 2014 |
$0 |
| 2014 |
$ |
| 2013 |
$0 |
| 2013 |
$ |
Acasti Pharma Quarterly Income Taxes
(Millions of US $) |
| 2024-06-30 |
$-1 |
| 2024-03-31 |
$-1 |
| 2023-12-31 |
$-0 |
| 2023-09-30 |
$-0 |
| 2023-06-30 |
$-0 |
| 2023-03-31 |
$-9 |
| 2022-12-31 |
$-0 |
| 2022-09-30 |
$-0 |
| 2022-06-30 |
$-0 |
| 2022-03-31 |
|
| 2021-12-31 |
|
| 2021-09-30 |
|
| 2021-06-30 |
|
| 2021-03-31 |
|
| 2020-12-31 |
|
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-03-31 |
|
| 2016-02-29 |
|
| 2015-12-31 |
$0 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
|
| 2014-12-31 |
$0 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
|
| 2014-02-28 |
|
| 2013-12-31 |
$0 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-GENERIC DRG |
$0.033B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
